Genetics to Brain Biomarkers in Kynurenine Pathway Dysfunction
犬尿氨酸通路功能障碍的脑生物标志物的遗传学
基本信息
- 批准号:10661740
- 负责人:
- 金额:$ 61.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-09 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAcetylcholineAllelesAwardBackBioinformaticsBiological AssayBiological MarkersBrainBrain imagingCRISPR/Cas technologyCell modelClinicalCognitionCognitiveCognitive deficitsComplementDataDevelopmentDiagnosisDopamineElectrophysiology (science)EnrollmentEnzymesFunctional disorderGene ExpressionGenesGeneticGenetic Predisposition to DiseaseGenetic TranscriptionGenetic VariationGenetic studyGenotypeGlucocorticoidsGlutamatesHumanImmuneImpairmentInterferon Type IIKnowledgeKynurenic AcidKynurenineKynurenine 3-monooxygenaseLaboratoriesLinkMeasuresMediatingMediationMicroRNAsModelingMolecular GeneticsMutationNeuronsParticipantPathway interactionsPatientsPeripheral Blood Mononuclear CellProcessProductionProteinsProteomicsReporterResearch PersonnelRisk FactorsRoleSamplingSchizophreniaSerotoninSignal PathwaySignal TransductionStressStructureSystemTestingTranscriptional RegulationTranslatingTryptophanTryptophan 2,3 DioxygenaseTryptophanaseVariantWestern BlottingWorkbiological adaptation to stressbiomarker identificationbrain circuitryclinical predictorsclinical translationcohortdesigndifferential expressiondrug developmentextracellular vesiclesgenetic approachgenome editingglutamatergic signalinginsightnovelpre-clinicalpromoterresponseschizophrenia spectrum disordertargeted treatmenttranscriptome sequencingwhite matter
项目摘要
Project summary
Perturbations in the kynurenine pathway metabolites have been associated with alterations in glutamate,
acetylcholine, serotonin and dopamine signaling, and have been linked to schizophrenia. During the first 5 year
of the Conte project, we have developed new evidence that kynurenergic effects in schizophrenia maybe
dynamically related to stress response and genetics. Identifying the underlying mechanism would be critical to
determine whether this pathway is critical in schizophrenia and how it is related to the known
pathophysiological glutamate, acetylcholine, serotonin and dopamine signaling in this illness. The downstream
substrates of the tryptophan-kynurenine mechanism involve multiple and frequently opposite actions. Although
many of these actions have implications in schizophrenia, the field lacks a coherent schizophrenia-kynurenine
model, hindering meaningful preclinical-clinical translations. The difficulty may be due to the inherent
complexity of the system and its interactions with genetics and developmental risk factors. We will employ a
combination of cellular to patient ex-vivo cellular genetic approaches to analyze the role genetic effects on the
kynurenine pathway signaling in schizophrenia. The empahsis is on stress-induced kynurenergic response and
its associated brain circuitry and glutamatergic signaling biomarkers. The project is ambitious and translational,
involving clinical, brain imaging, and cellular models for specific genetic effects. However, we have formed a
strong, highly integrated team and project design, and the preliminary studies support our proposed specific
aims, demonstrate feasibility, and suggest a significant potential for novel discoveries if these aims are
supported in the proposed studies. Knowledge on how the kynurenine pathway is involved in clinical
schizophrenia patients will lead to more specific and better treatment targets for drug development.
项目摘要
犬尿氨酸途径代谢物的扰动与谷氨酸的改变有关,
乙酰胆碱,血清素和多巴胺信号,并已与精神分裂症。在第一个5年
在Conte项目中,我们已经发现了新的证据,表明精神分裂症中的犬尿氨酸能效应可能
与压力反应和遗传学有着密切的关系。确定潜在的机制对于
确定这一途径是否在精神分裂症中至关重要,以及它与已知的
病理生理谷氨酸,乙酰胆碱,血清素和多巴胺信号在这种疾病。下游
Dahan-kynurenine机制的底物涉及多种且经常相反的作用。虽然
许多这些行动的影响,精神分裂症,该领域缺乏一个连贯的精神分裂症-犬尿氨酸
模式,阻碍有意义的临床前-临床翻译。困难可能是由于固有的
系统的复杂性及其与遗传和发育风险因素的相互作用。我们将雇用一名
细胞与患者离体细胞遗传学方法的组合,以分析基因作用对细胞的影响。
犬尿氨酸信号通路在精神分裂症中的作用重点是应激诱导的犬尿素能反应,
其相关的脑回路和神经元能信号生物标志物。该项目是雄心勃勃的和翻译,
涉及临床、脑成像和特定遗传效应的细胞模型。然而,我们已经形成了一个
强大的,高度整合的团队和项目设计,以及初步研究支持我们提出的具体
目标,证明可行性,并提出新发现的重大潜力,如果这些目标是
在拟议的研究中得到支持。了解犬尿氨酸途径如何参与临床
精神分裂症患者将导致更具体和更好的治疗药物开发的目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
L Elliot Elliot Hong其他文献
L Elliot Elliot Hong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('L Elliot Elliot Hong', 18)}}的其他基金
Towards Multisystem-Brain Successful Aging in Schizophrenia Spectrum
精神分裂症谱系迈向多系统大脑成功衰老
- 批准号:
9752660 - 财政年份:2018
- 资助金额:
$ 61.91万 - 项目类别:
Towards Multisystem-Brain Successful Aging in Schizophrenia Spectrum
精神分裂症谱系迈向多系统大脑成功衰老
- 批准号:
10392882 - 财政年份:2018
- 资助金额:
$ 61.91万 - 项目类别:
Towards Multisystem-Brain Successful Aging in Schizophrenia Spectrum
精神分裂症谱系迈向多系统大脑成功衰老
- 批准号:
9922360 - 财政年份:2018
- 资助金额:
$ 61.91万 - 项目类别:
The Role of Stress-Immune-Connectome Disruption in Mechanisms of Chinese Early Schizophrenia Spectrum
应激-免疫-连接体破坏在中国早期精神分裂症谱系机制中的作用
- 批准号:
10057388 - 财政年份:2017
- 资助金额:
$ 61.91万 - 项目类别:
Genetics to Brain Biomarkers in Kynurenine Pathway Dysfunction
犬尿氨酸通路功能障碍的脑生物标志物的遗传学
- 批准号:
10425363 - 财政年份:2014
- 资助金额:
$ 61.91万 - 项目类别:
Genetics to Brain Biomarkers in Kynurenine Pathway Dysfunction
犬尿氨酸通路功能障碍的脑生物标志物的遗传学
- 批准号:
10016396 - 财政年份:2014
- 资助金额:
$ 61.91万 - 项目类别:
Genetics to Brain Biomarkers in Kynurenine Pathway Dysfunction
犬尿氨酸通路功能障碍的脑生物标志物的遗传学
- 批准号:
10218011 - 财政年份:2014
- 资助金额:
$ 61.91万 - 项目类别:
Shared Neural Circuitry in Comorbid Schizophrenia and Nicotine Addiction
共病精神分裂症和尼古丁成瘾的共享神经回路
- 批准号:
8689997 - 财政年份:2010
- 资助金额:
$ 61.91万 - 项目类别:
相似海外基金
Spatiotemporal dynamics of acetylcholine activity in adaptive behaviors and response patterns
适应性行为和反应模式中乙酰胆碱活性的时空动态
- 批准号:
24K10485 - 财政年份:2024
- 资助金额:
$ 61.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Structural studies into human muscle nicotinic acetylcholine receptors
人体肌肉烟碱乙酰胆碱受体的结构研究
- 批准号:
MR/Y012623/1 - 财政年份:2024
- 资助金额:
$ 61.91万 - 项目类别:
Research Grant
CRCNS: Acetylcholine and state-dependent neural network reorganization
CRCNS:乙酰胆碱和状态依赖的神经网络重组
- 批准号:
10830050 - 财政年份:2023
- 资助金额:
$ 61.91万 - 项目类别:
Study on biological significance of acetylcholine and the content in food resources
乙酰胆碱的生物学意义及其在食物资源中的含量研究
- 批准号:
23K05090 - 财政年份:2023
- 资助金额:
$ 61.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
alpha7 nicotinic acetylcholine receptor allosteric modulation and native structure
α7烟碱乙酰胆碱受体变构调节和天然结构
- 批准号:
10678472 - 财政年份:2023
- 资助金额:
$ 61.91万 - 项目类别:
Diurnal Variation in Acetylcholine Modulation of Dopamine Dynamics Following Chronic Cocaine Intake
慢性可卡因摄入后乙酰胆碱对多巴胺动力学调节的昼夜变化
- 批准号:
10679573 - 财政年份:2023
- 资助金额:
$ 61.91万 - 项目类别:
Striatal Regulation of Cortical Acetylcholine Release
纹状体对皮质乙酰胆碱释放的调节
- 批准号:
10549320 - 财政年份:2022
- 资助金额:
$ 61.91万 - 项目类别:
Differential Nicotinic Acetylcholine Receptor Modulation of Striatal Dopamine Release as a Mechanism Underlying Individual Differences in Drug Acquisition Rates
纹状体多巴胺释放的烟碱乙酰胆碱受体差异调节是药物获取率个体差异的机制
- 批准号:
10553611 - 财政年份:2022
- 资助金额:
$ 61.91万 - 项目类别:
Mechanisms of nicotinic acetylcholine receptor modulation of cocaine reward
烟碱乙酰胆碱受体调节可卡因奖赏的机制
- 批准号:
10672207 - 财政年份:2022
- 资助金额:
$ 61.91万 - 项目类别:
Structural basis of nicotinic acetylcholine receptor gating and toxin inhibition
烟碱乙酰胆碱受体门控和毒素抑制的结构基础
- 批准号:
10848770 - 财政年份:2022
- 资助金额:
$ 61.91万 - 项目类别:














{{item.name}}会员




